Sepsis and Opioid Use Disorder: The Intersection of Two Public Health Crises

Sepsis and Opioid Use Disorder: The Intersection of Two Public Health Crises

5 (7 votes)

Recorded On: 01/27/2022

Description: 

Sepsis and opioid use disorders are major sources of morbidity, mortality, and costs to the healthcare system. While most of the national focus has been on the rising number of fatal opioid overdoses, less attention has been paid to the serious infectious complications of opioid use disorders, including sepsis.  In this presentation, Drs. Rhee and Kimmel will review recent data elucidating the epidemiology of sepsis and opioid-related hospitalizations and discuss potential strategies for reducing the harms associated with the intersection of these two public health emergencies.

Learning Objectives: 

At the end of the activity, the learner should be able to:

  • Review the major acute infectious complications of opioid use disorders;
  • Describe the prevalence, clinical characteristics, outcomes, and trends of sepsis and opioid-related hospitalizations;
  • Discuss integration of opioid use disorder treatment with sepsis care to reduce morbidity and mortality from both infections and opioid use disorder.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Simeon Kimmel, MD, MA

Assistant Professor of Medicine

Boston University School of Medicine and Boston Medical Center

Simeon Kimmel, MD, MA, is an Assistant Professor of Medicine at Boston University School of Medicine and an Attending Physician in the Sections of General Internal Medicine and Infectious Diseases at Boston Medical Center. He is Medical Director of Project TRUST, Boston Medical Center’s harm reduction-focused drop-in center. He trained in Internal Medicine and Primary Care at Brigham and Women’s Hospital before completing a joint fellowship in Addiction Medicine and Infectious Diseases at Boston Medical Center. He also earned a Master’s Degree in Medical Anthropology from the Harvard Graduate School of Arts and Sciences. His research focuses on improving retention in treatment with medications for opioid use disorder following serious injection-related infections as well as the integration of addiction and harm reduction services with infectious disease care. He was awarded a Career Development Award from NIDA in 2021.

Chanu Rhee, MD, MPH, FIDSA

Assistant Professor of Population Medicine

Harvard Pilgrim Health Care Institute / Harvard Medical School

Chanu Rhee, MD, MPH, is an Associate Professor of Population Medicine at Harvard Medical School and an infectious disease and critical care physician at Brigham and Women's Hospital.  He is internationally recognized for his contributions and expertise in the epidemiology, surveillance, diagnosis, prevention, and management of sepsis and infections in critically ill patients. He conducts clinical and epidemiologic research with a particular focus on harnessing electronic health record data to generate insights that advance clinical practice, quality improvement, public health strategy, and healthcare policy.  He has been a leader in sepsis quality improvement efforts within the Mass General Brigham system and has participated in many national committees focused on improving sepsis care and outcomes, including in his current role as Chair of the Infectious Diseases Society of America’s Sepsis Advisory Panel.  Dr. Rhee is an associate editor for Clinical Infectious Diseases, a member of the editorial boards for Critical Care Medicine and Critical Care Explorations, and a Fellow of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, and the American College of Critical Care Medicine.  

Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.6 contact hours.

Other healthcare professionals will receive a certificate of attendance for 1.25 contact hours.

Medical Disclaimer

The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

Components visible upon registration.